Clinical Trial Update: Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)

View source ↗

Summary

This clinical trial update summarizes a completed study examining the prevalence of polypharmacy in adults with newly diagnosed acute myeloid leukemia. It also …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: ACUTE MYELOGENOUS LEUKEMIA | Status: COMPLETED